cabozantinib
exelixis
['urothelial carcinoma', 'atlantis', 'cabozantinib', 'urothelial']
at this year's #asco22 in chicago, we had the opportunity to interview robert jones from on the atlantis trial which assessed maintenance cabozantinib in metastatic urothelial carcinoma. catch the full interview later at #uroonc 
The Video Journal of Oncology is dedicated to providing trusted information to improve knowledge, understanding and awareness of cancer. Intended for HCPs only.